| 臺大學術典藏 |
2021-06-02T05:43:49Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo T.-C.; Chiang P.-C.; Yu C.-C.; Nakagawa-Goto K.; Bastow K.F.; Lee K.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2020-12-28T05:56:09Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Guh J.-H.; Bastow K.F.; Lee K.-H.; Nakagawa-Goto K.; Yu C.-C.; Chiang P.-C.; TING-CHUN KUO |
| 臺大學術典藏 |
2020-12-02T02:34:23Z |
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents
|
Yang X.; Shi Q.; Liu Y.-N.; Zhao G.; Bastow K.F.; Lin J.-C.; Yang S.-C.; Pan-Chyr Yang; Lee K.-H.; Yang X.; Shi Q.; Liu Y.-N.; Zhao G.; Bastow K.F.; Lin J.-C.; Yang S.-C.; PAN-CHYR YANG; Lee K.-H. |
| 臺大學術典藏 |
2020-12-02T02:33:57Z |
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: Design, synthesis, and mechanistic studies
|
Yang X.; Shi Q.; Lai C.-Y.; Chen C.-Y.; Ohkoshi E.; Yang S.-C.; Wang C.-Y.; Bastow K.F.; Wu T.-S.; Pan S.-L.; Teng C.-M.; Pan-Chyr Yang; Lee K.-H.; Yang X.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-06-17T03:01:51Z |
Antitumor agents 283. Further elaboration of Desmosdumotin C analogs as potent antitumor agents: Activation of spindle assembly checkpoint as possible mode of action
|
Nakagawa-Goto K. ;Wu P.-C. ;Bastow K.F. ;Yang S.-C. ;Sung-Liang Yu ;Chen H.-Y. ;Lin J.-C. ;Goto M. ;Morris-Natschke S.L. ;Yang P.-C. ;Lee K.-H.; Nakagawa-Goto K.; Wu P.-C.; Bastow K.F.; Yang S.-C.; SUNG-LIANG YU; Chen H.-Y.; Lin J.-C.; Goto M.; Morris-Natschke S.L.; Yang P.-C.; Lee K.-H. |
| 臺大學術典藏 |
2020-06-17T03:01:50Z |
Antitumor agents 288: Design, synthesis, SAR, and biological studies of novel heteroatom-incorporated antofine and cryptopleurine analogues as potent and selective antitumor agents
|
Yang X. ;Shi Q. ;Yang S.-C. ;Chen C.-Y. ;Sung-Liang Yu ;Bastow K.F. ;Morris-Natschke S.L. ;Wu P.-C. ;Lai C.-Y. ;Wu T.-S. ;Pan S.-L. ;Teng C.-M. ;Lin J.-C. ;Yang P.-C. ;Lee K.-H.; Yang X.; Shi Q.; Yang S.-C.; Chen C.-Y.; SUNG-LIANG YU; Bastow K.F.; Morris-Natschke S.L.; Wu P.-C.; Lai C.-Y.; Wu T.-S.; Pan S.-L.; Teng C.-M.; Lin J.-C.; Yang P.-C.; Lee K.-H. |
| 臺大學術典藏 |
2018-09-10T08:30:27Z |
A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways
|
Kuo, T.-C.;Chiang, P.-C.;Yu, C.-C.;Nakagawa-Goto, K.;Bastow, K.F.;Lee, K.-H.;Guh, J.-H.; JIH-HWA GUH |
| 中國醫藥大學 |
2010 |
Antitumor agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent
|
(Usami, Y); (Nakagawa-Goto, K); (Lang, J-Y); (Kim, Y.); (Lai, C-Y); (Goto, M.); (Sakurai, N.); (Taniguchi, M); (Akiyama, T.); (Morris-Natschke, S. L.); (Bastow, K. F.); (Cragg, G.); (Newman, D.J.); (Fujitake, M.); (Takeya, K.); 洪明奇(Mien-Chie Hung); (Lee, E. Y-H. P.); (Lee, K-H.)* |
| 中國醫藥大學 |
2008-05 |
Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo.
|
彭婕妤(Chieh-Yu Peng); 潘秀玲(Pan, S.L.); 李國雄(Lee, K.H.); (Bastow, K.F.); 鄧哲明(Teng, C.M.)* |
| 中國醫藥大學 |
2007-07 |
Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs
|
(Nakagawa-Goto, K.); 陳姿璇(Chen, T.H.); 彭婕妤(Chieh-Yu Peng); (Bastow, K.F.); (Wu, J.H.); 李國雄(Lee, K.H.)* |
| 中國醫藥大學 |
2007-05 |
Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents.
|
(Nakagawa-Goto, K.); (Nakamura, S); (Bastow, K.F.); (Nyarko, A.); 彭婕妤(Chieh-Yu Peng); (Lee F.Y.); (Lee, F.C.); 李國雄(Lee, K.H.)* |
